{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:46:59Z","timestamp":1777542419092,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ihj.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T17:33:04Z","timestamp":1502904784000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease"],"prefix":"10.1016","volume":"70","author":[{"given":"Amit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahangir Rashid","family":"Beig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar A.","family":"Tramboo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dil","family":"Afroze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal A.","family":"Rather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2017.08.005_bib0005","series-title":"The Global Burden of Disease: 2004 Update","author":"Mathers","year":"2008"},{"key":"10.1016\/j.ihj.2017.08.005_bib0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0025-6196(12)62612-3","article-title":"Coronary heart disease in residents of Rochester, Minnesota,VII : incidence, 1950 through 1982","volume":"61","author":"Elvebac","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ihj.2017.08.005_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9149(72)90624-8","article-title":"Natural history of angina pectoris in the Framingham study: prognosis and survival","volume":"29","author":"Kannel","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ehj.2004.05.006","article-title":"Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era","volume":"25","author":"Agema","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2017.08.005_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2017.08.005_bib0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"De Lemos","year":"2001","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ihj.2017.08.005_bib0035","doi-asserted-by":"crossref","first-page":"E1412","DOI":"10.1016\/S0735-1097(12)61413-2","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-ProBNP) vs. BNP for predicting adverse outcomes in patients with stable Coronary artery disease: the heart and soul study","volume":"59","author":"Mishra","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0040","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/01.CIR.97.19.1921","article-title":"Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction","volume":"97","author":"Richards","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jacc.2004.04.033","article-title":"B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy","volume":"44","author":"Mega","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0735-1097(03)00168-2","article-title":"Evaluation of B-type natriuretic peptide for risk assessment in unstable angina\/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18","volume":"41","author":"Morrow","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2007.03.038","article-title":"Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial","volume":"50","author":"Omland","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease","volume":"352","author":"Kragelund","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2017.08.005_bib0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/hrt.2005.060350","article-title":"B-type natriuretic peptide identifies silent myocardial ischaemia in stroke survivors","volume":"92","author":"Wong","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2017.08.005_bib0075","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/oxfordjournals.eurheartj.a015169","article-title":"Right coronary artery stenosis is associated with impaired cardiac endocrine function during exercise","volume":"18","author":"Davidson","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2017.08.005_bib0080","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.0000103681.04726.9C","article-title":"B-type natriuretic peptide and ischemia in patients with stable coronary disease data from the Heart and Soul Study","volume":"108","author":"Bibbins-Domingo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jacc.2004.03.072","article-title":"Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction","volume":"44","author":"Sadanandan","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0090","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ahj.2004.04.021","article-title":"N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris","volume":"148","author":"Weber","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2017.08.005_bib0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjmed.2003.12.022","article-title":"Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function","volume":"116","author":"Nishikimi","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2017.08.005_bib0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/clc.4960231016","article-title":"Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty","volume":"23","author":"Tateishi","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0105","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/01.CIR.0000147611.92021.2B","article-title":"Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes","volume":"110","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1096\/fj.02-0796fje","article-title":"Increased cardiac BNP expression associated with myocardial ischemia","volume":"17","author":"Goetze","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.ihj.2017.08.005_bib0115","first-page":"186","article-title":"B-type natriuretic peptide and serum unbound free fatty acid levels after contemporary percutaneous coronary intervention","volume":"20","author":"Cantor","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0120","first-page":"282","article-title":"Effects of lesion complexity on baseline and post procedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions","volume":"34","author":"Yildirir","year":"2007","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.ihj.2017.08.005_bib0125","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.jacc.2007.02.064","article-title":"Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease","volume":"49","author":"McClure","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ihj.2015.06.034","article-title":"Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention","volume":"68","author":"Mehta","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2017.08.005_bib0135","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0002-9149(00)00790-6","article-title":"Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction","volume":"85","author":"Vanoverschelde","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejheart.2008.01.017","article-title":"BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction","volume":"10","author":"Grewal","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ihj.2017.08.005_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.88.2.461","article-title":"Comparative effects of ischemia and hypoxemia on left ventricular systolic and diastolic function in humans","volume":"88","author":"De Bruyne","year":"1993","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ihj.2017.08.005_bib0150","doi-asserted-by":"crossref","first-page":"E1398","DOI":"10.1016\/S0735-1097(12)61399-0","article-title":"The expression of brain natriuretic peptide m-RNA is up-regulated in ischemic heart tissue in vivo and in vitro","volume":"59","author":"Ye","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.08.005_bib0155","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.105.550715","article-title":"Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina","volume":"112","author":"Ndrepepa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0160","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes","volume":"106","author":"Omland","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0165","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/hrt.2005.071423","article-title":"B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes","volume":"92","author":"Rana","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2017.08.005_bib0170","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0175","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2017.08.005_bib0180","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0185","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/CIRCULATIONAHA.111.071811","article-title":"Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York","volume":"125","author":"Hannan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2017.08.005_bib0190","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216309750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483216309750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T13:52:41Z","timestamp":1535464361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483216309750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0019483216309750"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2017.08.005","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}